Bayforest Capital’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
VCM
VPM
Bayforest Capital's ADPT Position: Q1 2026 in Review
Bayforest Capital reduced its Adaptive Biotechnologies (ADPT) stake by 5% in Q1 2026, selling an estimated $6.93K and leaving 8,290 shares worth $115K. The position accounts for 0.13% of the portfolio, ranked #313.
Bayforest Capital first reported a position in ADPT in Q4 2025 and has held it in 2 quarters since. The position peaked at $142K in Q4 2025. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.
- Bayforest Capital held 8,290 shares of Adaptive Biotechnologies worth $115K as of Q1 2026.
- Bayforest Capital sold 435 Adaptive Biotechnologies shares in Q1 2026, an estimated $6.93K.
- Adaptive Biotechnologies made up 0.13% of Bayforest Capital's portfolio in Q1 2026, its #313 holding.
- Bayforest Capital first reported a position in Adaptive Biotechnologies in Q4 2025 and has held it in 2 quarters since.
- Bayforest Capital's Adaptive Biotechnologies position peaked at $142K in Q4 2025.
- 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.
Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.